SCHEMBL14353293

SCHEMBL14353293

Cc1n[nH]c2cc(F)c(C=C(C#N)C(=O)c3ccc(Cl)cc3)cc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.38
ALDH1A1 P00352 5/20 0.38
KMT2A Q03164 4/20 0.38
POLB P06746 3/20 0.38
PKM P14618 2/20 0.38
MAPT P10636 7/20 0.37
TP53 P04637 4/20 0.37
LMNA P02545 3/20 0.37
HPGD P15428 3/20 0.37
TDP1 Q9NUW8 3/20 0.37
MAPK1 P28482 3/20 0.37
NFKB1 P19838 2/20 0.37
MEN1 O00255 2/20 0.37
USP2 O75604 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
ALOX15 P16050 2/20 0.37
ALOX12 P18054 2/20 0.37
THPO P40225 2/20 0.37
RECQL P46063 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14353292 1.00 KDM4E (0.38) KDM4EALDH1A1KMT2APOLBPKM
SCHEMBL12596373 1.00 KDM4E (0.38) KDM4EALDH1A1KMT2APOLBPKM
SCHEMBL14353073 0.92 EGFR (0.46) KDM4EALDH1A1KMT2APOLBPKM
SCHEMBL14353071 0.92 EGFR (0.46) KDM4EALDH1A1KMT2APOLBPKM
SCHEMBL12595594 0.92 EGFR (0.46) KDM4EALDH1A1KMT2APOLBPKM
SCHEMBL561253 0.82 ALDH1A1 (0.37) KDM4EALDH1A1KMT2APOLBMAPT
SCHEMBL561254 0.82 ALDH1A1 (0.37) KDM4EALDH1A1KMT2APOLBMAPT
SCHEMBL562281 0.68 ADORA2A (0.44) KDM4EALDH1A1KMT2AMAPTMAPK1
SCHEMBL182614 0.64 NEK2 (0.51) KDM4EALDH1A1KMT2APOLBPKM
SCHEMBL182613 0.64 NEK2 (0.51) KDM4EALDH1A1KMT2APOLBPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2499124-B1 FLUORO-SUBSTITUTED 2-ARYL-3,5-DICYANO-4-INDAZOLYL-6-METHYL-1,4-DIHYDROPYRIDINES AND USES THEREOF BAYER IP GMBH (DE) 2015-08-19 EP disclosed
US-9018234-B2 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-04-28 US disclosed
US-20130005773-A1 FLUORO-SUBSTITUTED 2-ARYL-3,5-DICYANO-4-INDAZOLYL-6-METHYL-1,4-DIHYDROPYRIDINES AND USES THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130005773-A1 FLUORO-SUBSTITUTED 2-ARYL-3,5-DICYANO-4-INDAZOLYL-6-METHYL-1,4-DIHYDROPYRIDINES AND USES THEREOF MET, RET, ABL1 KDM4E 467/4885ALDH1A1 1223/4885KMT2A 691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.